StockNews.com upgraded shares of Cemtrex (NASDAQ:CETX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday morning. Cemtrex Price Performance CETX opened at $3.09 on Friday. The company has a debt-to-equity ratio of 48.20, a quick ratio of 1.35 and a current ratio of 1.89. […]

StockNews.com upgraded shares of Amdocs (NASDAQ:DOX – Free Report) from a buy rating to a strong-buy rating in a report published on Monday. Several other equities analysts have also issued reports on the company. Oppenheimer raised their price objective on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a report […]

StockNews.com upgraded shares of Catalyst Pharmaceuticals (NASDAQ:CPRX – Free Report) from a buy rating to a strong-buy rating in a research note published on Friday. Several other analysts have also recently issued reports on CPRX. Stephens began coverage on Catalyst Pharmaceuticals in a research report on Monday, November 18th. They set an “overweight” rating and […]